UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (65268) 65268
Book Chapter (2098) 2098
Patent (1598) 1598
Conference Proceeding (920) 920
Newspaper Article (259) 259
Dissertation (140) 140
Magazine Article (113) 113
Publication (76) 76
Book / eBook (32) 32
Government Document (29) 29
Web Resource (11) 11
Paper (6) 6
Book Review (5) 5
Trade Publication Article (5) 5
Newsletter (3) 3
Reference (2) 2
Report (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (45460) 45460
humans (33603) 33603
life sciences & biomedicine (30174) 30174
male (26455) 26455
female (24474) 24474
middle aged (20217) 20217
stroke volume (17285) 17285
aged (16157) 16157
cardiovascular system & cardiology (15944) 15944
cardiac & cardiovascular systems (15404) 15404
adult (11998) 11998
technology (11407) 11407
physical sciences (9311) 9311
abridged index medicus (8133) 8133
analysis (7417) 7417
heart failure (6835) 6835
stroke volume - physiology (6835) 6835
echocardiography (6093) 6093
engineering (5822) 5822
volume fraction (5805) 5805
volumenfraktion (5592) 5592
heart failure - physiopathology (5469) 5469
treatment outcome (5427) 5427
prognosis (4903) 4903
time factors (4890) 4890
ventricular function, left (4866) 4866
animals (4736) 4736
studies (4610) 4610
prospective studies (4604) 4604
risk factors (4551) 4551
follow-up studies (4500) 4500
materials science (4457) 4457
radiology, nuclear medicine & medical imaging (4429) 4429
physics (4372) 4372
aged, 80 and over (4197) 4197
mathematical models (4121) 4121
chemistry (3968) 3968
retrospective studies (3937) 3937
volume-fraction (3833) 3833
cardiology (3751) 3751
heart (3300) 3300
electrocardiography (3292) 3292
asset pricing, trading volume, bond interest rates (3274) 3274
cardiovascular (3252) 3252
ventricular dysfunction, left - physiopathology (3205) 3205
research (3148) 3148
care and treatment (3129) 3129
predictive value of tests (3117) 3117
ventricular function, left - physiology (3016) 3016
stroke volume - drug effects (2868) 2868
reproducibility of results (2829) 2829
computer simulation (2780) 2780
respiratory system (2760) 2760
heart ventricles - physiopathology (2742) 2742
materials science, multidisciplinary (2738) 2738
magnetic resonance imaging (2734) 2734
mortality (2677) 2677
blood pressure (2618) 2618
adolescent (2584) 2584
cardiac patients (2518) 2518
heart ventricles - diagnostic imaging (2508) 2508
severity of illness index (2505) 2505
medicine & public health (2489) 2489
mechanics (2472) 2472
patients (2420) 2420
general & internal medicine (2390) 2390
myocardial infarction - physiopathology (2388) 2388
volume (2332) 2332
chemistry, physical (2313) 2313
cardiac output (2306) 2306
social sciences (2290) 2290
surgery (2289) 2289
hemodynamics (2242) 2242
physiology (2171) 2171
engineering, chemical (2151) 2151
business & economics (2132) 2132
thermodynamics (2111) 2111
heart rate (2095) 2095
algorithms (2064) 2064
ventricular dysfunction, left - diagnostic imaging (2044) 2044
exercise test (2041) 2041
sensitivity and specificity (2015) 2015
myocardial contraction (1971) 1971
peripheral vascular disease (1945) 1945
usage (1923) 1923
heart attacks (1919) 1919
mathematical analysis (1909) 1909
cardiovascular disease (1826) 1826
multivariate analysis (1824) 1824
heart failure - drug therapy (1812) 1812
heart failure - diagnosis (1779) 1779
risk assessment (1742) 1742
computational fluid dynamics (1731) 1731
heart diseases (1720) 1720
testing (1700) 1700
cardiology and cardiovascular medicine (1697) 1697
young adult (1679) 1679
health aspects (1660) 1660
heart failure - mortality (1660) 1660
systole (1613) 1613
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Engineering & Comp. Sci. - Stacks (3) 3
Online Resources - Online (3) 3
Gerstein Science - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
OISE - Curriculum Resources (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (68258) 68258
Chinese (1067) 1067
Japanese (1028) 1028
French (845) 845
German (688) 688
Portuguese (339) 339
Russian (278) 278
Spanish (264) 264
Italian (134) 134
Norwegian (112) 112
Korean (97) 97
Polish (82) 82
Czech (41) 41
Turkish (26) 26
Dutch (20) 20
Hungarian (19) 19
Lithuanian (18) 18
Serbian (17) 17
Ukrainian (15) 15
Danish (14) 14
Slovak (13) 13
Croatian (11) 11
Chamorro (9) 9
Indonesian (4) 4
Romanian (4) 4
Arabic (3) 3
Bulgarian (3) 3
Persian (3) 3
Swedish (3) 3
Afrikaans (1) 1
Greek (1) 1
Hebrew (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Heart and vessels, ISSN 1615-2573, 10/2017, Volume 33, Issue 4, pp. 403 - 412
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2018, Volume 72, Issue 4, pp. 351 - 366
Background: Guidelines strongly recommend patients with heart failure with reduced ejection fraction (HFrEF... 
reduced ejection fraction | registry | dose | medication | Severity of Illness Index | Mineralocorticoid Receptor Antagonists - administration & dosage | United States - epidemiology | Age Factors | Humans | Middle Aged | Heart Failure - physiopathology | Male | Socioeconomic Factors | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Dose-Response Relationship, Drug | Stroke Volume | Quality Improvement | Registries - statistics & numerical data | Female | Aged | Angiotensin Receptor Antagonists - therapeutic use | Heart Failure - epidemiology | Adrenergic beta-Antagonists - administration & dosage | Drug Utilization - statistics & numerical data | Adrenergic beta-Antagonists - therapeutic use | Angiotensin Receptor Antagonists - administration & dosage | Practice Guidelines as Topic | Heart failure | Care and treatment | Enzyme inhibitors | Analysis | Cardiac patients | Health care | Angiotensin-converting enzyme inhibitors | Drugs | Therapy | Cardiac arrhythmia | Health services | Medical records | Clinical trials | Cardiovascular disease | Secondary schools | Regulatory approval | Renal insufficiency | Peptidyl-dipeptidase A | Blood pressure | Cardiology | Angiotensin II | Heart diseases | Age | Hypertension | Mortality | Hospitalization | Patients | Asthma | Heart rate | Ethnicity | Inhibitors | Coronary vessels | Angiotensin | Neprilysin | Diabetes | Clinical medicine | Females | Hispanics | Ejection fraction | Index Medicus | Abridged Index Medicus
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 12/2014, Volume 130, Issue 25, pp. 2310 - 2320
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2019, Volume 381, Issue 21, pp. 1995 - 2008
...–glucose cotransporter 2 inhibitor dapagliflozin in patients with heart failure and a reduced ejection fraction with or without type 2 diabetes... 
NEPRILYSIN INHIBITION | OUTCOMES | COTRANSPORTER 2 INHIBITORS | MECHANISM | EMPAGLIFLOZIN | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Glycated Hemoglobin A - analysis | Humans | Middle Aged | Ventricular Dysfunction, Left - complications | Male | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - mortality | Female | Glucosides - therapeutic use | Drug Therapy, Combination | Benzhydryl Compounds - therapeutic use | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Heart Failure - complications | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Kaplan-Meier Estimate | Stroke Volume - drug effects | Combined Modality Therapy | Hospitalization | Heart Failure - drug therapy | Cardiovascular Agents - therapeutic use | Diabetes Mellitus, Type 2 - blood | Ventricular Dysfunction, Left - drug therapy | Aged | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Measurement | Heart failure | Dapagliflozin | Patient outcomes | Physiological aspects | Cardiac output | Drug therapy | Testing | Intravenous administration | Renal function | Clinical trials | Hypoglycemia | Evidence-based medicine | Clinical outcomes | Sodium | Hemoglobin | Patient safety | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Ejection fraction | Index Medicus | Abridged Index Medicus | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2019, Volume 381, Issue 17, pp. 1609 - 1620
Patients with heart failure with preserved ejection fraction were assigned to receive sacubitril... 
MIDDLE CHILD | MIDRANGE | IMPAIRED SYSTOLIC FUNCTION | SPIRONOLACTONE | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Single-Blind Method | Valsartan - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heart Failure - physiopathology | Aminobutyrates - adverse effects | Hospitalization - statistics & numerical data | Male | Tetrazoles - administration & dosage | Cardiovascular Diseases - mortality | Female | Aminobutyrates - administration & dosage | Double-Blind Method | Valsartan - adverse effects | Hypotension - chemically induced | Heart Failure - drug therapy | Stroke Volume | Neprilysin - antagonists & inhibitors | Sex Factors | Quality of Life | Angioedema - chemically induced | Aged | Tetrazoles - adverse effects | Angiotensin Receptor Antagonists - administration & dosage | Angiotensin Receptor Antagonists - adverse effects | Heart failure | Treatment outcome | Care and treatment | Usage | Safety and security measures | Hospitals | Patient outcomes | Analysis | Angiotensin | Causes of | Statistics | Admission and discharge | Renal function | Cardiomyopathy | Mortality | Angioedema | Clinical trials | Hospitalization | Coronary artery disease | Hypotension | Heart rate | Hyperkalemia | Patient safety | Death | Neprilysin | Heart diseases | Pharmaceuticals | Ejection fraction | Index Medicus | Abridged Index Medicus
Journal Article
Soft matter, ISSN 1744-683X, 12/2011, Volume 8, Issue 1, pp. 21 - 3
Journal Article